Lauren M. Stanoszek

Lauren M. Stanoszek

Auto-generated profile, based on publicly available information

Lauren M. Stanoszek

College of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Clinical Lymphoma Myeloma and Leukemia
Verified
Journal Article
Closed access
LSLauren M. Stanoszek
Lauren M. Stanoszek
LSLauren B. Smith
Lauren B. Smith
KGKaren Grajewski
Karen Grajewski
JRJohn Reneau
John Reneau
RWRyan Wilcox
Ryan Wilcox
APAnamarija M. Perry
Anamarija M. Perry

17 September 2025 in bioRxiv
Verified
Preprint
Open access
JBJoshua Breidenbach
Joshua Breidenbach
Bivek TimalsinaBivek Timalsina
Bivek Timalsina
BFBenjamin French
Benjamin French
LSLauren Stanoszek
Lauren Stanoszek
JLJohn-Paul Lavik
John-Paul Lavik
DKDavid J. Kennedy
David J. Kennedy
Microcystin-LR (MC-LR) is one of a large family of cyanotoxins which are naturally produced by cyanobacteria within harmful algal blooms occurring in bodies of water globally. Early findings of the toxicity of such blooms stemmed from fatalities of livestock drinking from affected water. Since then, various toxins have been identified such as the microcystins. Microcystin-LR has been studied as a representative congener due to its abundance and toxicity. While there have been extensive studies of microcystin-LR by oral route exposure, we have turned our attention to inhalation route exposure due to the recent findings of microcystin-containing lake and sea-spray aerosol. We have shown inflammatory outcomes in the airways of mice and in human cell culture models after microcystin aerosol exposure, and have found a consistent molecular patterns similar to those of Type 1/Type 17 driven neutrophilic asthma. Here we address the hypothesis that MC-LR will increase the inflammatory mediators of neutrophilic asthma leading to worsening symptoms. This is tested and characterized in both in vitro and in vivo models. We found that asthma symptoms and molecular signatures of inflammation are both worsened by MC-LR exposure in a mouse model of neutrophilic asthma. We found that 3D human airway cell culture models reconstructed from asthmatic donor cells are similarly affected, however healthy donor cells are nearly unaltered by comparison. Aggregating these findings with RNA sequencing data from all models, we developed a hypothetical molecular mechanism which relies on MC-LR mediated amplification of existing inflammatory signaling. We test this in a human reporter cell line of NF-κB activity and further demonstrate the mechanism by inhibitor testing. This study sheds light on the risk to asthmatic patients living near or recreating on affected bodies of water. Beyond asthma, we believe this study provides crucial insight into the findings over the last 40 years concerning disparate outcomes of MC-LR exposure as the result of exposure will be dependent on the signaling state of the tissue upon exposure.